| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5701087 | European Journal of Surgical Oncology (EJSO) | 2017 | 5 Pages |
Abstract
Blood fibrinogen differed between low and high risk IPMNs and therefore, the use of fibrinogen as an additional discriminator in the pre-operative risk assessment of IPMNs should be further evaluated.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
M.F. Nentwich, K. Menzel, M. Reeh, F.G. Uzunoglu, T. Ghadban, K. Bachmann, J. Schrader, M. Bockhorn, J.R. Izbicki, D. Perez,